Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:04 pm Purchase |
2025-02-28 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
TANG CAPITAL MANAGEMENT LLC | 10,029,500 7.300% |
2,800,000 (+38.73%) |
Filing History |
| 2025-02-14 5:05 pm Sale |
2024-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 6,400,000 4.470% |
-1,800,000 (-21.95%) |
Filing History |
| 2024-11-14 4:47 pm Sale |
2024-09-30 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 8,200,000 5.730% |
-1,336,000 (-14.01%) |
Filing History |
| 2024-09-12 4:10 pm Purchase |
2024-09-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
TANG CAPITAL MANAGEMENT LLC | 7,229,500 5.100% |
7,229,500 (New Position) |
Filing History |
| 2024-03-20 5:23 pm Purchase |
2024-03-20 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,539,891 13.000% |
355,993 (+4.96%) |
Filing History |
| 2024-02-14 3:27 pm Purchase |
2023-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 9,536,000 6.640% |
9,536,000 (New Position) |
Filing History |
| 2024-02-12 09:41 am Purchase |
2023-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
BLACKROCK INC BLK |
8,921,049 6.200% |
750,531 (+9.19%) |
Filing |
| 2023-05-10 4:30 pm Unchanged |
2023-05-10 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,183,898 13.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 08:29 am Sale |
2022-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Deep Track Capital, LP | 324,238 0.230% |
-7,517,332 (-95.87%) |
Filing History |
| 2023-02-07 12:59 pm Purchase |
2022-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
BLACKROCK INC BLK |
8,170,518 5.700% |
8,170,518 (New Position) |
Filing |
| 2023-01-20 4:30 pm Unchanged |
2023-01-19 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,183,898 13.000% |
0 (Unchanged) |
Filing History |
| 2023-01-06 4:30 pm Sale |
2023-01-06 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 7,183,898 13.000% |
-1,093,902 (-13.21%) |
Filing History |
| 2022-10-28 4:10 pm Purchase |
2022-10-18 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Deep Track Capital, LP | 7,841,570 5.530% |
7,841,570 (New Position) |
Filing History |
| 2022-03-03 4:15 pm Sale |
2022-02-28 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
ILJIN SNT Co. Ltd. | 8,277,800 13.000% |
-717,639 (-7.98%) |
Filing History |
| 2022-02-14 10:30 am Sale |
2021-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
HealthCor Management L.P. | 0 0.000% |
-6,937,448 (Position Closed) |
Filing History |
| 2021-03-10 9:41 pm Sale |
2021-02-24 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
Growth Equity Opportunities Fund III LLC | 0 0.000% |
-5,593,342 (Position Closed) |
Filing History |
| 2021-02-17 2:22 pm Sale |
2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Consonance Capital Management LP | 0 0.000% |
-6,058,505 (Position Closed) |
Filing History |
| 2021-02-16 2:19 pm Sale |
2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Consonance Capital Management LP | 6,058,505 11.000% |
-567,166 (-8.56%) |
Filing History |
| 2021-02-12 4:09 pm Purchase |
2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
HealthCor Management L.P. | 6,937,448 5.500% |
1,116,808 (+19.19%) |
Filing History |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
FMR CORP | 5,762,773 4.557% |
-2,267,285 (-28.23%) |
Filing History |